We are live on ! Find out more
RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Delisted

RARX was delisted on the 1st of April, 2020.

Back to rankings

1 hedge funds and large institutions have $32K invested in Ra Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 142 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 144 → 1 (-143)

100% less funds holding in top 10

Funds holding in top 10: 11 → 0 (-11)

100% less capital invested

Capital invested by funds: $2.47B → $32K (-$2.47B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 142

Holders
1
Holders Change
-143
Holders Change %
-99.31%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
142
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$295M
2
RCM
RA Capital Management
Massachusetts
-$233M
3
BlackRock
BlackRock
New York
-$213M
4
BBA
Baker Bros. Advisors
New York
-$101M
5
AAM
Alpine Associates Management
Florida
-$96.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
126
Panagora Asset Management
Massachusetts
– -$160K -3,327 Closed
AIP
127
Ameritas Investment Partners
Nebraska
– -$147K -3,058 Closed
DekaBank Deutsche Girozentrale
128
DekaBank Deutsche Girozentrale
Germany
– -$140K -3,000 Closed
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
– -$134K -2,787 Closed
Simplex Trading
130
Simplex Trading
Illinois
– -$126K -2,629 Closed
Canada Life
131
Canada Life
Manitoba, Canada
– -$92K -1,904 Closed
AIM
132
Aigen Investment Management
New York
– -$60K -1,256 Closed
SO
133
STRS Ohio
Ohio
– -$43K -900 Closed
Royal Bank of Canada
134
Royal Bank of Canada
Ontario, Canada
– -$34K -700 Closed
CG
135
Cutler Group
California
– -$24K -500 Closed
FTCM
136
First Trust Capital Management
Illinois
– -$21K -446 Closed
FHA
137
Flagship Harbor Advisors
Massachusetts
– -$13K -270 Closed
Osaic Holdings
138
Osaic Holdings
Arizona
– -$11K -230 Closed
TRCT
139
Tower Research Capital (TRC)
New York
– -$6K -121 Closed
VCM
140
Versant Capital Management
Arizona
– -$5K -118 Closed
US Bancorp
141
US Bancorp
Minnesota
– -$5K -109 Closed
AssetMark Inc
142
AssetMark Inc
California
– -$1K -25 Closed
2 3 4 5
6

RARX Hedge Fund Activity: Q2 2020 in Review

1 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Ra Pharmaceuticals, Inc. Common Stock (RARX) for Q2 2020, worth a combined $32K — down 100% from $2.47B a quarter earlier.

Sellers outnumbered buyers: 142 funds closed out of RARX and 0 opened new positions — a net loss of 142 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was NEA Management Company, exiting entirely with an estimated $295M sold.

  • 1 institutional investor held Ra Pharmaceuticals, Inc. Common Stock (RARX) as of Q2 2020, down from 144 in Q1 2020.
  • Funds reported $32K of Ra Pharmaceuticals, Inc. Common Stock stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Ra Pharmaceuticals, Inc. Common Stock positions in Q2 2020 and 142 closed out, a net change of -142 holders.
  • The largest Ra Pharmaceuticals, Inc. Common Stock seller in Q2 2020 was NEA Management Company, an estimated $295M sold.

Based on aggregated 13F filings for Q2 2020.